Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry

Analytical Biochemistry

Volumn 324, Issue 2, 2004, Pages 276-284

  Baker, Sharyn D ^a   Zhao, Ming ^a   He, Ping ^a   Carducci, Michael A ^a   Verweij, Jaap ^b   Sparreboom, Alex ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Docetaxel; LC MS MS; Pharmacokinetics; Polysorbate 80 (Tween 80)

Indexed keywords

CHLORINE COMPOUNDS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; PHARMACOKINETICS; PLASMA (HUMAN);

DOCETAXEL; LC/MS/MS; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; LOWER LIMITS OF QUANTITATIONS; SIMULTANEOUS ANALYSIS; SIMULTANEOUS DETERMINATIONS; TWEEN 80;

DRUG PRODUCTS;

ACETONITRILE; ANTINEOPLASTIC AGENT; CHLORIDE; DOCETAXEL; PACLITAXEL; POLYSORBATE 80;

ACCURACY; ANALYTIC METHOD; ARTICLE; CANCER; CANCER PATIENT; CONTROLLED STUDY; DEVICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG ISOLATION; ELECTROSPRAY; ELUTION; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 0345731209     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.09.038     Document Type: Article

References (24)

1. Piccart M. The role of taxanes in the adjuvant treatment of early stage breast cancer. Breast Cancer Res. Treat. 79(Suppl. 1):2003;S25-S34.
2. Simon G.R., Bunn P.A. Jr. Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. Cancer Invest. 21:2003;87-104.
3. Shou M., Martinet M., Korzekwa K.R., Krausz K.W., Gonzalez F.J., Gelboin H.V. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver. Pharmacogenetics. 8:1998;391-401.
4. Bardelmeijer H.A., Ouwehand M., Buckle T., Huisman M.T., Schellens J.H., Beijnen J.H., van Tellingen O. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir. Cancer Res. 62:2002;6158-6164.
5. Goh B.C., Lee S.C., Wang L.Z., Fan L., Guo J.Y., Lamba J., Schuetz E., Lim R., Lim H.L., Ong A.B., Lee H.S. Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies. J. Clin. Oncol. 20:2002;3683-3690.
6. Bruno R., Vivier N., Veyrat-Follet C., Montay G., Rhodes G.R. Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel. Invest. New Drugs. 19:2001;163-169.
7. Ten Tije A., Verweij J., Loos W., Sparreboom A. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin. Pharmacokinet. 42:2003;665-685.
8. Crispens C.G. Jr., Sorenson J.R. Treatment of reticulum cell sarcoma in SJL/J mice with Tween 80. Anticancer Res. 8:1988;1341-1343.
9. Loos W.J., Szebeni J., ten Tije A.J., Verweij J., van Zomeren D.M., Chung K.N., Nooter K., Stoter G., Sparreboom A. Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel. Anticancer Drugs. 13:2002;767-775.
10. Loos W.J., Baker S.D., Verweij J., Boonstra J., Sparreboom A. Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins. Clin. Pharmacol. Ther. 74:2003;364-371.
11. Ardiet C.J., Tranchand B., Zanetta S., Guillot A., Bernard E., Peguy M., Rebattu P., Droz J.P. A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokinetics. Invest. New Drugs. 17:1999;325-333.
12. Ciccolini J., Catalin J., Blachon M.F., Durand A. Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction. J. Chromatogr. B Biomed. Sci. Appl. 759:2001;299-306.
13. Garg M.B., Ackland S.P. Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine. J. Chromatogr. B Biomed. Sci. Appl. 748:2000;383-388.
14. Loos W.J., Verweij J., Nooter K., Stoter G., Sparreboom A. Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 693:1997;437-441.
15. Rosing H., Lustig V., Koopman F.P., ten Bokkel Huinink W.W., Beijnen J.H. Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction. J. Chromatogr. B Biomed. Sci. Appl. 696:1997;89-98.
16. Rouini M.R., Lotfolahi A., Stewart D.J., Molepo J.M., Shirazi F.H., Vergniol J.C., Tomiak E., Delorme F., Vernillet L., Giguere M., Goel R. A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere) in human plasma using a column switching technique. J. Pharm. Biomed. Anal. 17:1998;1243-1247.
17. Vergniol J.C., Bruno R., Montay G., Frydman A. Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method. J. Chromatogr. 582:1992;273-278.
18. Gustafson D.L., Long M.E., Zirrolli J.A., Duncan M.W., Holden S.N., Pierson A.S., Eckhardt S.G. Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay. Cancer Chemother. Pharmacol. 2003.
19. Parise R.A., Ramanathan R.K., Zamboni W.C., Egorin M.J. Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 783:2003;231-236.
20. Wang L.Z., Goh B.C., Grigg M.E., Lee S.C., Khoo Y.M., Lee H.S. A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma. Rapid Commun. Mass Spectrom. 17:2003;1548-1552.
21. Sparreboom A., Zhao M., Brahmer J.R., Verweij J., Baker S.D. Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 773:2002;183-190.
22. Sottani C., Minoia C., D'Incalci M., Paganini M., Zucchetti M. High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol) in human plasma. Rapid Commun. Mass Spectrom. 12:1998;251-255.
23. van Tellingen O., Beijnen J.H., Verweij J., Scherrenburg E.J., Nooijen W.J., Sparreboom A. Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin. Cancer Res. 5:1999;2918-2924.
24. Hartmann C., Smeyers-Verbeke J., Massart D.L., McDowall R.D. Validation of bioanalytical chromatographic methods. J. Pharm. Biomed. Anal. 17:1998;193-218.